Processa Pharmaceuticals Inc expected to post a loss of 98 cents a share - Earnings Preview

Processa Pharmaceuticals

07/08/2024 01:27

* Processa Pharmaceuticals Inc  PCSA.OQ   PCSA.O  is
expected
to report resultson August 8 (estimated) for the period ending
June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Processa Pharmaceuticals
Inc
is for a loss of 98 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Processa
Pharmaceuticals Inc is $44.00​, above​ its last closing price
of $1.86. ​​​

This summary was machine generated August 7 at 00:27 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)